Patents by Inventor Radmila Hrdlickova

Radmila Hrdlickova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENETIC TEST FOR DETECTING CONGENITAL ADRENAL HYPERPLASIA
    Publication number: 20210102246
    Abstract: A method for amplifying a CYP21A2 gene and/or a CYP21A2 gene chimera from a sample is provided. In some embodiments, the method may comprise amplifying a product from a sample comprising human genomic DNA by PCR using a forward primer that is complementary to a sequence that is duplicated in a bimodular human RCCX locus and a reverse primer that is complementary to a sequence that occurs only once in the bimodular human RCCX locus at a position that is downstream of the CYP21A2 gene. Methods for analyzing the amplification product are also provided.
    Type: Application
    Filed: December 15, 2020
    Publication date: April 8, 2021
    Inventors: Colby Clear, Radmila Hrdlickova, Jiri Nehyba, Dylan Fox
  • Genetic test for detecting congenital adrenal hyperplasia
    Patent number: 10894978
    Abstract: A method for amplifying a CYP21A2 gene and/or a CYP21A2 gene chimera from a sample is provided. In some embodiments, the method may comprise amplifying a product from a sample comprising human genomic DNA by PCR using a forward primer that is complementary to a sequence that is duplicated in a bimodular human RCCX locus and a reverse primer that is complementary to a sequence that occurs only once in the bimodular human RCCX locus at a position that is downstream of the CYP21A2 gene. Methods for analyzing the amplification product are also provided.
    Type: Grant
    Filed: December 19, 2017
    Date of Patent: January 19, 2021
    Assignee: BIOO SCIENTIFIC CORPORATION
    Inventors: Colby Clear, Radmila Hrdlickova, Jiri Nehyba, Dylan Fox
  • GENETIC TEST FOR DETECTING CONGENITAL ADRENAL HYPERPLASIA
    Publication number: 20190185925
    Abstract: A method for amplifying a CYP21A2 gene and/or a CYP21A2 gene chimera from a sample is provided. In some embodiments, the method may comprise amplifying a product from a sample comprising human genomic DNA by PCR using a forward primer that is complementary to a sequence that is duplicated in a bimodular human RCCX locus and a reverse primer that is complementary to a sequence that occurs only once in the bimodular human RCCX locus at a position that is downstream of the CYP21A2 gene. Methods for analyzing the amplification product are also provided.
    Type: Application
    Filed: December 19, 2017
    Publication date: June 20, 2019
    Inventors: Colby Clear, Radmila Hrdlickova, Jiri Nehyba, Dylan Fox